Exelixis, Inc. (EXEL) Analyst Forecast

$45.72

$2.35 (5.42%)
Last update: 04:00 PM EST
Day's range
$43.95
Day's range
$46.14

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
05/15/2025 Guggenheim Michael Schmidt $45.00 $46.26   -2.72%
05/14/2025 Morgan Stanley Sean Laaman $47.00 $36.98   27.1%
01/27/2025 JMP Securities Silvan Tuerkcan $41.00 $32.38   26.62%
01/10/2025 H.C. Wainwright Robert Burns $40.00 $36.02   11.05%
01/07/2025 Guggenheim Michael Schmidt $42.00 $34.21   22.77%
10/30/2024 BMO Capital Etzer Darout $36.00 $32.56   10.57%
10/30/2024 Truist Financial Asthika Goonewardene $38.00 $28.73   32.27%
10/30/2024 Piper Sandler Joseph Catanzaro $36.00 $28.73   25.3%
10/30/2024 Citigroup David Lebowitz $38.00 $28.73   32.27%
10/16/2024 Leerink Partners Christopher Liu $28.50 $28.50   0%
10/16/2024 RBC Capital Kennen MacKay $34.00 $28.50   19.3%
10/16/2024 Goldman Sachs Chris Shibutani $18.00 $28.50   -36.84%
10/15/2024 Jefferies Akash Tewari $33.00 $28.80   14.6%
10/15/2024 Morgan Stanley Jeffrey Hung $30.00 $28.50   5.26%
10/14/2024 Truist Financial Asthika Goonewardene $33.00 $26.24   25.76%
10/14/2024 Stephens Sudan Loganathan $23.00 $26.24   -12.33%
10/11/2024 Morgan Stanley Jeffrey Hung $28.00 $25.97   7.82%
09/19/2024 UBS Ashwani Verma $30.00 $26.82   11.86%
09/16/2024 Citigroup David Lebowitz $31.00 $26.46   17.16%
09/04/2024 Bank of America Securities Jason Gerberry $30.00 $25.44   17.95%
08/08/2024 H.C. Wainwright Robert Burns $29.00 $26.52   9.35%
08/07/2024 JMP Securities Silvan Tuerkcan $29.00 $23.45   23.67%
05/20/2024 New Street David Lebowitz $31.00 $21.06   47.2%
05/20/2024 BMO Capital George Farmertzer Darout $29.00 $21.07   37.67%
04/10/2024 Barclays Peter Lawson $25.00 $23.68   5.57%
06/27/2021 Guggenheim Michael Schmidt $30.00 $18.02   66.48%
05/17/2021 Goldman Sachs Chris Shibutani $23.00 $24.34   -5.51%
04/18/2021 Morgan Stanley Jeffrey Hung $26.00 $23.74   9.52%

Exelixis, Inc. FAQ's

Exelixis, Inc. has been rated by research analysts at Guggenheim, Morgan Stanley, RBC Capital, JMP Securities, H.C. Wainwright, BMO Capital in the past 90 days.